HD vs. LLY: Home Depot vs. Eli Lilly Stock Comparison
How do Home Depot (HD) and Eli Lilly (LLY) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Home Depot (HD) is classified in the Consumer Discretionary sector (Consumer Discretionary Distribution & Retail), whereas Eli Lilly (LLY) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.
| Profile Item | HD | LLY |
|---|---|---|
| Name | The Home Depot, Inc. | Eli Lilly and Company |
| Country/Region | United States | United States |
| GICS Sector | Consumer Discretionary | Health Care |
| GICS Industry Group | Consumer Discretionary Distribution & Retail | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Specialty Retail | Pharmaceuticals |
| GICS Sub-Industry | Home Improvement Retail | Pharmaceuticals |
| Market Capitalization | 338.26 billion USD | 1,199.93 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | September 22, 1981 | June 1, 1972 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | HD | LLY |
|---|---|---|
| Total Return (1Y) | 4.89% | 29.90% |
| Total Return (3Y, Annualized) | 5.91% | 31.99% |
| Total Return (5Y, Annualized) | -1.20% | 40.09% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | HD | LLY |
|---|---|---|
| Volatility (1Y, Annualized) | 27.38% | 35.39% |
| Beta (5Y) | 0.86 | 0.43 |
| Max Drawdown (5Y) | -34.73% | -34.48% |
| Avg. Volume (3M) | 4.80M | 2.59M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | HD | LLY |
|---|---|---|
| Sharpe Ratio (1Y) | 0.01 | 0.71 |
| Sortino Ratio (1Y) | 0.02 | 1.19 |
Profitability
ROE (TTM)
Both companies show strong equity returns, but Home Depot (HD) at 94.80% is the standout with ROE above its industry range; Eli Lilly (LLY) at 86.02% also sits in the top quartile.
HD
Consumer Discretionary Distribution & Retail industry group
94.80%
- HD
- 94.80%
- Max
- 61.40%
- Q3
- 30.30%
- Median
- 15.79%
- Q1
- 7.77%
- Min
- -8.40%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
86.02%
- Max
- 109.18%
- LLY
- 86.02%
- Q3
- 8.19%
- Median
- -26.53%
- Q1
- -61.44%
- Min
- -151.05%
Net Margin (TTM)
Eli Lilly (LLY) at 31.90% converts revenue to bottom-line profit above its industry’s benchmark range, while Home Depot (HD) at 8.38% keeps roughly the typical share for its industry.
HD
Consumer Discretionary Distribution & Retail industry group
8.38%
- Max
- 20.47%
- Q3
- 9.34%
- HD
- 8.38%
- Median
- 3.97%
- Q1
- 1.29%
- Min
- -9.41%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
31.90%
- LLY
- 31.90%
- Max
- 18.98%
- Q3
- 5.73%
- Median
- 0.00%
- Q1
- -3.30%
- Min
- -16.57%
Operating Margin (TTM)
Both Home Depot (HD) at 12.35% and Eli Lilly (LLY) at 51.25% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
HD
Consumer Discretionary Distribution & Retail industry group
12.35%
- Max
- 23.22%
- HD
- 12.35%
- Q3
- 11.30%
- Median
- 6.16%
- Q1
- 2.55%
- Min
- -2.67%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
51.25%
- Max
- 80.14%
- LLY
- 51.25%
- Q3
- 14.17%
- Median
- 0.00%
- Q1
- -65.77%
- Min
- -156.86%
Profitability Metrics
| Metric | HD | LLY |
|---|---|---|
| ROE (TTM) | 94.80% | 86.02% |
| ROA (TTM) | 12.22% | 21.06% |
| Net Margin (TTM) | 8.38% | 31.90% |
| Operating Margin (TTM) | 12.35% | 51.25% |
| Gross Margin (TTM) | 33.05% | 83.63% |
Growth
Revenue Growth
Both Home Depot (HD) at 3.24% and Eli Lilly (LLY) at 44.70% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Eli Lilly (LLY) at 95.99% sits in the top EPS growth quartile, while Home Depot (HD) at -4.56% is closer to the peer norm — faster per-share earnings growth for LLY.
Growth Metrics
| Metric | HD | LLY |
|---|---|---|
| Revenue Growth (YoY) | 3.24% | 44.70% |
| Revenue Growth (3Y CAGR) | 1.52% | 31.69% |
| EPS Growth (YoY) | -4.56% | 95.99% |
| EPS Growth (3Y CAGR) | -5.18% | 51.71% |
Financial Strength
Current Ratio (MRQ)
Home Depot (HD) at 1.08 keeps current ratio within its industry’s typical mid-range, while Eli Lilly (LLY) at 1.39 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for LLY.
HD
Consumer Discretionary Distribution & Retail industry group
1.08
- Max
- 2.69
- Q3
- 1.74
- Median
- 1.36
- HD
- 1.08
- Q1
- 1.08
- Min
- 0.63
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.39
- Max
- 23.95
- Q3
- 11.13
- Median
- 5.04
- Q1
- 2.43
- LLY
- 1.39
- Min
- 0.13
Debt / Equity (MRQ)
Both Home Depot (HD) at 3.42 and Eli Lilly (LLY) at 1.23 lean more heavily on debt funding than most peers, landing in the higher-leverage quartile of their industries.
HD
Consumer Discretionary Distribution & Retail industry group
3.42
- Max
- 3.93
- HD
- 3.42
- Q3
- 2.03
- Median
- 1.25
- Q1
- 0.71
- Min
- 0.01
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.23
- Max
- 1.44
- LLY
- 1.23
- Q3
- 0.67
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
Financial Strength Metrics
| Metric | HD | LLY |
|---|---|---|
| Current Ratio (MRQ) | 1.08 | 1.39 |
| Debt / Equity (MRQ) | 3.42 | 1.23 |
| Net Debt / EBITDA | 2.35 | 0.96 |
Dividends
Dividend Yield (TTM)
Home Depot (HD) at 0.69% pays an industry-typical yield; Eli Lilly (LLY) at 0.50% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.
HD
Consumer Discretionary Distribution & Retail industry group
0.69%
- Max
- 5.44%
- Q3
- 2.38%
- HD
- 0.69%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.50%
- LLY
- 0.50%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both pay out more than their industries’ typical bands, and LLY more so: Home Depot (HD) at 64.80% sits above the band, while Eli Lilly (LLY) at 21.71% exceeds every peer in its group.
HD
Consumer Discretionary Distribution & Retail industry group
64.80%
- Max
- 73.08%
- HD
- 64.80%
- Q3
- 32.26%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
21.71%
- LLY
- 21.71%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | HD | LLY |
|---|---|---|
| Dividend Yield (TTM) | 0.69% | 0.50% |
| Dividend Payout Ratio (TTM) | 64.80% | 21.71% |
Valuation
P/E Ratio (TTM)
Eli Lilly (LLY) at 43.72 is near its industry’s usual P/E ratio, while Home Depot (HD) at 23.54 sits in the richer quartile — HD needs stronger growth or earnings quality to justify the premium.
HD
Consumer Discretionary Distribution & Retail industry group
23.54
- Max
- 36.35
- HD
- 23.54
- Q3
- 22.25
- Median
- 17.98
- Q1
- 11.86
- Min
- 4.22
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
43.72
- Max
- 91.23
- Q3
- 44.74
- LLY
- 43.72
- Median
- 26.53
- Q1
- 13.26
- Min
- 0.06
P/S Ratio (TTM)
Eli Lilly (LLY) at 13.88 is priced about in line with its industry on P/S ratio, while Home Depot (HD) at 1.98 sits in the pricier quartile — HD costs more per dollar of sales.
HD
Consumer Discretionary Distribution & Retail industry group
1.98
- Max
- 3.79
- HD
- 1.98
- Q3
- 1.72
- Median
- 0.65
- Q1
- 0.27
- Min
- 0.03
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
13.88
- Max
- 46.64
- Q3
- 20.90
- LLY
- 13.88
- Median
- 6.79
- Q1
- 3.12
- Min
- 0.01
P/B Ratio (MRQ)
Measured against book value, both Home Depot (HD) at 18.60 and Eli Lilly (LLY) at 29.81 look expensive — each P/B ratio sits above its industry’s benchmark range.
HD
Consumer Discretionary Distribution & Retail industry group
18.60
- HD
- 18.60
- Max
- 11.12
- Q3
- 5.25
- Median
- 2.06
- Q1
- 1.08
- Min
- -4.63
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
29.81
- LLY
- 29.81
- Max
- 11.93
- Q3
- 6.36
- Median
- 3.19
- Q1
- 1.69
- Min
- -5.31
Valuation Metrics
| Metric | HD | LLY |
|---|---|---|
| P/E Ratio (TTM) | 23.54 | 43.72 |
| P/S Ratio (TTM) | 1.98 | 13.88 |
| P/B Ratio (MRQ) | 18.60 | 29.81 |
| Free Cash Flow Yield (TTM) | 3.56% | 0.78% |